IDEAS home Printed from https://ideas.repec.org/p/hrv/faseco/5343031.html
   My bibliography  Save this paper

Trends in Thrombolytic Use for Ischemic Stroke in the United States

Author

Listed:
  • Cutler, David M.
  • Rosen, Allison B.
  • Fang, Margaret C.

Abstract

BACKGROUND: Although recombinant tissue plasminogen activator (tPA) improves outcomes from ischemic stroke, prior studies have found low rates of administration. Recent guidelines and regulatory agencies have advocated for increased tPA administration in appropriate patients, but it is unclear how many patients actually receive tPA. OBJECTIVE: To determine whether national rates of tPA use for ischemic stroke have increased over time. METHODS: We identified all patients with a primary diagnosis of ischemic stroke from years 2001 to 2006 in the National Hospital Discharge Survey (NHDS), a nationally representative sample of inpatient hospitalizations, and searched for procedure codes for intravenous thrombolytic administration. Clinical and demographic factors were obtained from the survey and multivariable logistic regression used to identify independent predictors associated with thrombolytic use. RESULTS: Among the 22,842 patients hospitalized with ischemic stroke, tPA administration rates increased from 0.87% in 2001 to 2.40% in 2006 (P

Suggested Citation

  • Cutler, David M. & Rosen, Allison B. & Fang, Margaret C., 2010. "Trends in Thrombolytic Use for Ischemic Stroke in the United States," Scholarly Articles 5343031, Harvard University Department of Economics.
    • Handle: RePEc:hrv:faseco:5343031
    as

    Download full text from publisher

    File URL: http://dash.harvard.edu/bitstream/handle/1/5343031/Trends%20in%20Thrombolytic.pdf
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yi-Ju Tseng & Ru-Fang Hu & Shin-Tyng Lee & Yu-Li Lin & Chien-Lung Hsu & Shih-Wei Lin & Chia-Wei Liou & Jiann-Der Lee & Tsung-I Peng & Tsong-Hai Lee, 2020. "Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke," IJERPH, MDPI, vol. 17(2), pages 1-12, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hrv:faseco:5343031. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Office for Scholarly Communication (email available below). General contact details of provider: https://edirc.repec.org/data/deharus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.